sar425899 dual agonist glp-1 glucagon sanofi Frontiers Retatrutide, a GIP, GLP-1 and

Barreling into March 2025 and as states start to pull together their own budgets, Colorado is not the only state considering pulling back or in some way limiting their coverage either through state employee health plans or in Medicaid of GLP-1s for treating obesity

GLP-1s: A Head-to-Head Comparison Lets put the speedboat and the cruise ship side-by-side

[DOI] [PMC free article] [PubMed] [Google Scholar] [19].Lewis AL, Richard J, Challenges in the delivery of peptide drugs: an industry perspective, Therapeutic Delivery 6(2) (2015) 149163

[DOI] [PMC free article] [PubMed] [Google Scholar] 95.Kristensen SL, Rorth R, Jhund PS, Docherty KF, Sattar N, Preiss D, et al

10.1038/s41598-021-88612-x 45 KimM.PlattM